Improved Efficacy of Proton Pump Inhibitor - Amoxicillin - Clarithromycin Triple Therapy forHelicobacter pyloriEradication in Low Clarithromycin Resistance Areas or for Tailored Therapy

Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype

(2012) M. Sugimoto et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection

(2012) A. G. McNicholl et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: A pilot study

(2011) Taraq A Attumi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Sequential therapy in clarithromycin-sensitive and -resistant Helicobacter pylori based on polymerase chain reaction molecular test

(2011) Varocha Mahachai et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Optimal therapy for Helicobacter pylori infections

(2011) Emiko Rimbara et al.   Nature Reviews Gastroenterology & Hepatology

Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection

(2010) Takahisa Furuta et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States

(2010) David Y. Graham et al.   JOURNAL OF GASTROENTEROLOGY

High-dose versus standard-dose PPI in triple therapy for Helicobacter pylori eradication

(2009) Mitsushige Sugimoto et al.   Nature Reviews Gastroenterology & Hepatology

Efficient Identification and Evaluation of Effective Helicobacter pylori Therapies

(2008) David Y. Graham   Clinical Gastroenterology and Hepatology